An online series of Cancer Conversations for health professionals to share knowledge, learnings and opinions on the most current information relevant to cancer treatment and care.
Cancer Conversations is an after-hours event where you can tune in to hear from health professionals sharing their knowledge, learnings and opinions on the most current information relevant to cancer treatment and care.
Our first event is "Cancer Conversation: Cardio-Oncology.
Join our guest speakers for insights on the latest developments in practice changing cancer research, treatment and care.
- Prof Tom Marwick will share his insights on imaging for early detection of cancer cardiotoxicity
- A/Prof Eng-Siew Koh will share her thoughts on cardiotoxicity as related to Radiation Oncology
- Professor Bodga Koczwara, will share her thoughts on cancer cardiotoxicity as related to Medical Oncology
|Date||24 November 2020|
Register for the event before the 22nd of November
Professor Tom Marwick
Tom Marwick completed training in medicine and cardiology in Australia, before undertaking an Imaging Fellowship at Cleveland Clinic, a PhD at the University of Louvain, Belgium and a Masters in Public Health at Harvard.
He is Director of Baker Heart and Diabetes Institute and has divided his career mostly between Australia (formerly at the Menzies Institute for Medical Research and Professor of Medicine and Head of Cardiovascular Imaging Research Centre, UQ) and the USA (former Head of Cardiovascular Imaging at Cleveland Clinic).
His main contribution has been in clinical research and research training, and has supervised over 30 research higher degree students – mainly clinical – including 25 completed PhDs. He was one of the initiators of stress echocardiography, and has made contributions to the prognostic evidence underlying cardiovascular imaging.
His main current research interests relate to the detection of early cardiovascular disease and cost-effective application of cardiac imaging techniques for treatment selection and monitoring. He has published over 650 papers, reviews, chapters and editorials, and is an Associate Editor at JACC and Deputy Editor at JACC-Cardiovascular Imaging.
Professor Bogda Koczwara
Professor Bogda Koczwara is a senior staff specialist in medical oncology at the Flinders Medical Centre in Adelaide, Australia and she leads the Survivorship Research Program at the Flinders University Health and Medical Research Institute. She chairs the Psychosocial Group of the Multinational Association of Supportive Care in Cancer and leads the Global Partnership on Self-management in Cancer.
Professor Koczwara is the past President of the Clinical Oncology Society of Australia (COSA), the peak cancer professional organisation in Australia and the past president of the Medical Oncology Group of Australia (MOGA), the national professional organisation of medical oncologists. She is the initiator and the immediate past Chair the Australia Asia Pacific Clinical Oncology Research Development, a collaborative of international cancer organisations aimed at improving cancer research capacity in Australia and Asia Pacific.
Professor Koczwara has been recognized as a Member of the Order of Australia in January 2015 for her services to oncology through clinical practice, education and research and through a range of professional organisations.
Associate Professor Eng-Siew Koh
Associate Professor Eng-Siew Koh is a Senior Staff Specialist in Radiation Oncology at Liverpool Hospital, NSW and a Conjoint Associate Professor at the University of New South Wales with over 17 years’ experience as a clinician researcher. She has sub-specialty interests in neuro-oncology, breast, lung, and haematological cancers. Her current major research directions include all aspects of neuro-oncology research and secondly - cancer survivorship research including novel models of care and late effects of cancer therapies with a focus on cardio-oncology and the effects of chemotherapy and radiation on cardiovascular function.
Since 2015, she has received research support of $16.6 million (CI involvement) in competitive funding, including $14.5 million in brain tumour-related projects and $2.1 million in cancer survivorship research including the $2 million funded ACRF OASIS Survivorship research collaborative.
Associate Professor Koh has 40 peer-reviewed publications and holds several national leadership roles in neuro-oncology, being the Chair-Elect of the Cooperative Trials Group for Neuro-Oncology (COGNO), Deputy Chair of COGNO (2017-2020, Chair of the Clinical Oncology Society of Australia-Neuro-oncology (2011 to current). She has been a COSA Survivorship Conference Committee member for 2019 and 2021 and will be a Session speaker and Chairing at the COSA ASM 2020 with a specific focus on cardio-oncology.
Stay tuned for future events.